Change in Okmetic's financial reporting



Okmetic Oyj ("Okmetic") announced earlier today that it has applied for the termination of trading with and the delisting of its shares from Nasdaq Helsinki Ltd conditional upon NSIG Finland S.à r.l. having gained ownership to all of the issued and outstanding shares in Okmetic that are not owned by Okmetic or any of its subsidiaries in the redemption proceedings concerning minority shares in Okmetic in accordance with the Finnish Limited Liability Companies Act.

As a result of the minority share redemption proceedings and the application for the termination of trading and the delisting of shares, the board of directors of Okmetic has resolved that the company will not publish interim report Q3. This marks a change to the financial reporting timetable announced earlier by the company, according to which the company would publish an interim report Q3 on Thursday 27 October 2016. Pursuant to the amendment of the Finnish Securities Markets Act that entered into force on 26 November 2015 listed companies are no longer obliged to publish interim reports for the first three and nine months of their financial periods.


Kai Seikku

For further information, please contact:

Kai Seikku, President
Tel. +358 9 5028 0232, e-mail:

Tapio Hyvärinen, CFO
Tel. +358 5028 0408, e-mail:

Okmetic supplies tailored, high value-added silicon wafers to be used in the manufacture of sensors as well as discrete semiconductors and analog circuits. Okmetic's strategic objective is profitable growth driven by a product portfolio designed to meet customers' current and future technology needs. The core of the company's operations is being genuinely close to the customers and understanding their needs and processes.

Okmetic's global sales network, extensive portfolio of high value-added products, in-depth knowledge of crystal growing, long-term product development projects, as well as efficient and flexible production create prerequisites for achieving the strategic targets. The company's headquarters is located in Finland, where the majority of the company's silicon wafers is manufactured. In addition to in-house manufacture, Okmetic has contract manufacturing in Japan and China. Okmetic's shares are listed on Nasdaq Helsinki Ltd under the code OKM1V. For more information on the company, please visit our website at

OKME3616_change in financial reporting

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Okmetic Oyj via GlobeNewswire